| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5474535 | MYLAN SPECIALITY LP | Dosage and inserter for treatment of erectile dysfunction |
Dec, 2012
(11 years ago) | |
| US5886039 | MYLAN SPECIALITY LP | Method and composition for treating erectile dysfunction |
Mar, 2016
(8 years ago) | |
Muse is owned by Mylan Speciality Lp.
Muse contains Alprostadil.
Muse has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Muse are:
- US5474535
- US5886039
Muse was authorised for market use on 19 November, 1996.
Muse is available in suppository;urethral dosage forms.
Muse can be used as treatment of erectile dysfunction.
The generics of Muse are possible to be released after 23 March, 2016.
Drugs and Companies using ALPROSTADIL ingredient
Market Authorisation Date: 19 November, 1996
Treatment: Treatment of erectile dysfunction
Dosage: SUPPOSITORY;URETHRAL
More Information on Dosage
MUSE family patents
